BDKRB2 can promote angiogenesis by increasing vascular permeability and upregulating vascular endothelial growth factor (VEGF) [57] and can also promote tumor cell migration and invasion through TRPM7, MMP2, endothelin-1, and ERK signaling pathways [58]. This evidence concerns the gene VEGFA and neoplasm.